FI960803A0 - TNF-alpha secretion inhibitors - Google Patents
TNF-alpha secretion inhibitorsInfo
- Publication number
- FI960803A0 FI960803A0 FI960803A FI960803A FI960803A0 FI 960803 A0 FI960803 A0 FI 960803A0 FI 960803 A FI960803 A FI 960803A FI 960803 A FI960803 A FI 960803A FI 960803 A0 FI960803 A0 FI 960803A0
- Authority
- FI
- Finland
- Prior art keywords
- tnf
- secretion inhibitors
- alpha secretion
- alpha
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11060193A | 1993-08-23 | 1993-08-23 | |
US18301994A | 1994-01-18 | 1994-01-18 | |
PCT/US1994/009343 WO1995006031A1 (en) | 1993-08-23 | 1994-08-19 | Inhibitors of tnf-alpha secretion |
Publications (2)
Publication Number | Publication Date |
---|---|
FI960803A0 true FI960803A0 (en) | 1996-02-22 |
FI960803A FI960803A (en) | 1996-04-22 |
Family
ID=26808203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI960803A FI960803A (en) | 1993-08-23 | 1996-02-22 | TNF-alpha secretion inhibitors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0715619A4 (en) |
JP (1) | JPH09503201A (en) |
AU (2) | AU687436B2 (en) |
CA (1) | CA2170158A1 (en) |
FI (1) | FI960803A (en) |
NO (1) | NO960723D0 (en) |
NZ (1) | NZ271893A (en) |
WO (1) | WO1995006031A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9702487A (en) * | 1994-10-05 | 1998-04-30 | Darwin Discovery Ltd | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases. |
EP0826000B1 (en) * | 1995-05-10 | 2002-10-23 | Darwin Discovery Limited | Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
WO1996035711A1 (en) * | 1995-05-10 | 1996-11-14 | Chiroscience Limited | Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
CA2217859A1 (en) * | 1995-05-10 | 1996-11-14 | David Alan Owen | Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
US6406901B1 (en) | 1995-06-08 | 2002-06-18 | Immunex Corporation | TNF-a converting enzyme |
US5883241A (en) * | 1995-09-05 | 1999-03-16 | Celltech Therapeutics Limited | DNA sequences coding for a human metalloproteinase and variants thereof |
DE69625506T2 (en) * | 1995-10-05 | 2003-07-24 | Darwin Discovery Ltd | SULFUR-SUBSTITUTED PEPTIDES AS INHIBITORS FOR METALLOPROTEINASES AND TNF RELEASE |
US5665777A (en) * | 1995-11-14 | 1997-09-09 | Abbott Laboratories | Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
JP2000500761A (en) | 1995-11-23 | 2000-01-25 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | Metalloproteinase inhibitors |
GB9607120D0 (en) * | 1996-04-04 | 1996-06-12 | Chiroscience Ltd | Compounds |
US5990293A (en) * | 1996-09-05 | 1999-11-23 | Celltech Therapeutics Limited | Human metalloproteinase, variants thereof and DNA sequence coding therefor |
ATE220660T1 (en) | 1996-09-10 | 2002-08-15 | British Biotech Pharm | CYTOSTATIC HYDROXAMIC ACID DERIVATIVES |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
ZA9818B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
AU730308B2 (en) * | 1997-06-18 | 2001-03-01 | Rockefeller University, The | Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
EP1021173A1 (en) * | 1997-10-10 | 2000-07-26 | Imperial College Innovations Limited | Use of csaid?tm compounds for the management of uterine contractions |
GB9810464D0 (en) | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
GB9818605D0 (en) | 1998-08-26 | 1998-10-21 | Glaxo Group Ltd | Formamide compounds as therepeutic agents |
US6172064B1 (en) | 1998-08-26 | 2001-01-09 | Glaxo Wellcome Inc. | Formamides as therapeutic agents |
US6329400B1 (en) | 1998-08-26 | 2001-12-11 | Glaxo Wellcome Inc. | Formamide compounds as therapeutic agents |
US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
WO2000018358A2 (en) * | 1998-09-30 | 2000-04-06 | The Procter & Gamble Company | Method of treating hair loss using ketoamides |
US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
EP1117372A2 (en) * | 1998-09-30 | 2001-07-25 | The Procter & Gamble Company | Method of treating hair loss using sulfonamides |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
US6329550B1 (en) | 1998-12-31 | 2001-12-11 | Aventis Pharmaceuticals Inc. | Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase |
IL143795A0 (en) * | 1999-01-13 | 2002-04-21 | Jomaa Pharmaka Gmbh | Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections |
US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
WO2002028829A2 (en) * | 2000-09-25 | 2002-04-11 | Questcor Pharmaceuticals, Inc. | Peptide deformylase inhibitors |
PE20030701A1 (en) | 2001-12-20 | 2003-08-21 | Schering Corp | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |
BR112021006407A8 (en) | 2018-10-04 | 2022-12-06 | Inst Nat Sante Rech Med | use of egfr inhibitors for keratoderms |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE55375T1 (en) * | 1984-12-19 | 1990-08-15 | Ciba Geigy Ag | NEW CARBON ESTERS. |
FR2609289B1 (en) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | NOVEL COMPOUNDS HAVING ACTIVITY OF COLLAGENASE INHIBITORS, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
WO1992022523A2 (en) * | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
-
1994
- 1994-08-19 CA CA002170158A patent/CA2170158A1/en not_active Abandoned
- 1994-08-19 EP EP94925940A patent/EP0715619A4/en not_active Ceased
- 1994-08-19 JP JP7507668A patent/JPH09503201A/en active Pending
- 1994-08-19 WO PCT/US1994/009343 patent/WO1995006031A1/en not_active Application Discontinuation
- 1994-08-19 AU AU75694/94A patent/AU687436B2/en not_active Ceased
- 1994-08-19 NZ NZ271893A patent/NZ271893A/en unknown
-
1996
- 1996-02-22 FI FI960803A patent/FI960803A/en unknown
- 1996-02-23 NO NO960723A patent/NO960723D0/en unknown
-
1998
- 1998-01-06 AU AU50302/98A patent/AU5030298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU7569494A (en) | 1995-03-21 |
EP0715619A4 (en) | 1997-03-19 |
NO960723L (en) | 1996-02-23 |
WO1995006031A1 (en) | 1995-03-02 |
NZ271893A (en) | 1997-11-24 |
AU687436B2 (en) | 1998-02-26 |
EP0715619A1 (en) | 1996-06-12 |
CA2170158A1 (en) | 1995-03-02 |
JPH09503201A (en) | 1997-03-31 |
NO960723D0 (en) | 1996-02-23 |
FI960803A (en) | 1996-04-22 |
AU5030298A (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI960803A (en) | TNF-alpha secretion inhibitors | |
NO932620D0 (en) | AMINDIOL protease inhibitors | |
NO942064D0 (en) | inhibitors | |
NO972930D0 (en) | Fibronectin-adhesion inhibitors | |
FI972160A (en) | Matriisimetalloproteaasi inhibitors | |
NO20006717D0 (en) | protease inhibitors | |
FI943234A0 (en) | Human Kunitzt type protease inhibitor variant | |
FI964342A (en) | Halomethylamides as IL-1beta protease inhibitors | |
FI961725A (en) | Ramp | |
DE4492389T1 (en) | Cleaning aid | |
MX9100121A (en) | ASPARTICAL PROTEASE INHIBITORS | |
DE69431454T2 (en) | Amylase inhibitors | |
DE59409862D1 (en) | Timer | |
CY2007006I2 (en) | ALIPOPROTEIN-B INHIBITORS | |
KR950017128U (en) | Dressing equipment | |
FI941265A (en) | Heterocyclic sulfonamidotrombin inhibitors | |
DE9415245U1 (en) | Ramp | |
BR9301563A (en) | Generous - well thought out | |
FI1600U1 (en) | Bojhakes regel | |
FI933459A0 (en) | VAERMEVAEXLARE I KOMBINATION MED VARMVATTEN- OCH AONGBEREDARPANNA | |
SE9301969D0 (en) | RULE | |
DE9312701U1 (en) | Rapid dressing | |
DK0720454T3 (en) | implant | |
FI1301U1 (en) | Handtvaettmaskin med straole Foer baotar | |
FI1388U1 (en) | Saeng med stoedanordning |